CDCR-Rank: a computational model for predicting drug combination dose response using ranking-based optimization
Authors:
- Mohammadamin MoraghebMMMohammadamin Moragheb
- Karim AbbasiKAKarim Abbasi
- Parvin RazzaghiPRParvin Razzaghi
- Alireza DehghanADAlireza Dehghan
- Sajjad GharaghaniSGSajjad Gharaghani
Open Access
- 18 May 2026
- journal article
- Vol. 6 (1)
Abstract
Predicting synergistic drug combinations for cancer therapies is vital but challenged by interaction complexity and vast combinatorial possibilities. To address this, we propose a novel ranking-based approach for drug synergy prediction. Our method builds upon the pre-trained CDCR model to predict absolute synergy scores and introduces a novel architecture to directly compare a list of combinations. A key innovation is our custom loss function, which combines mean squared error with a ranking loss term to simultaneously learn accurate synergy values and their correct relative ordering. We comprehensively evaluated our model, CDCR-Rank, on the NCI-ALMANAC benchmark under three challenging scenarios, including predicting synergy for novel drug pairs without monotherapy data. CDCR-Rank demonstrated superior performance, consistently outperforming state-of-the-art methods such as comboFM and comboLTR. Ablation studies validated the importance of each component: a one-dimensional convolutional neural network (1D-CNN) for generating task-specific drug representations from SMILES strings, a sinusoidal encoder for modeling non-linear dose-response curves, and the uRank loss for optimizing combination rankings. Our integrated framework achieves significantly improved accuracy and robustness in predicting drug synergy. By reliably prioritizing the most promising combinations for experimental validation, this work has the potential to accelerate the discovery of effective multi-drug cancer therapies. CDCR-Rank is implemented in Python and is available at https://github.com/ParvinRazzaghi/CDCR-RankKeywords
This publication has 16 references indexed in Scilit:
- Predicting tumor cell line response to drug pairs with deep learningBMC Bioinformatics, 2018
- Bayesian Additive Adaptive Basis Tensor Product Models for Modeling High Dimensional Surfaces: An Application to High-Throughput Toxicity TestingBiometrics, 2018
- The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic ActivityCancer Research, 2017
- A Review of Modeling Approaches to Predict Drug Response in Clinical OncologyYonsei Medical Journal, 2017
- Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorizationBioinformatics, 2016
- Prediction of multidimensional drug dose responses based on measurements of drug pairsProceedings of the National Academy of Sciences, 2016
- Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and AcademiaThe Journal of Infectious Diseases, 2015
- A New Drug Combinatory Effect Prediction Algorithm on the Cancer Cell Based on Gene Expression and Dose–Response CurveCPT: Pharmacometrics & Systems Pharmacology, 2015
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical PropertiesPLOS ONE, 2013
- The Integration of Pharmacokinetics and Pharmacodynamics: Understanding Dose-ResponseAnnual Review of Pharmacology and Toxicology, 2004